Martin Reck
German Center for Lung Research
ORCID: 0000-0002-5348-4462Also affiliated with LungenClinic Grosshansdorf
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou +10 more
Papers
Driven by 4 papers — median percentile 69. Top paper: “Phase II trial of ipilimumab (IPI) and paclitaxel/carboplatin (P/C) in first-line stage IIIb/IV non-small cell lung cancer (NSCLC).”.
I. N. Bondarenko, A. Luft, P. Serwatowski, Fabrice Barlesi, R. T. Chacko +14 more
Delvys Rodríguez-Abreu, Andrew G. Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp +16 more
Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis +34 more
Mathilde Marchand, Kenta Yoshida, Phyllis Chan, Haocheng Li, Wei Zou +10 more